Pair Name | Ginsenoside Ro, Fluorouracil | ||
Phytochemical Name | Ginsenoside Ro (PubChem CID: 11815492 ) | ||
Anticancer drug Name | Fluorouracil (PubChem CID: 3385 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Ginsenoside Ro, Fluorouracil | |||
Disease Info | [ICD-11: 2B70] | Esophageal cancer | Investigative | |
Biological Phenomena | Induction-->Autophagy | |||
Gene Regulation | Up-regulation | Expression | ATG7 | hsa10533 |
Down-regulation | Activity | CTSB | hsa1508 | |
Down-regulation | Activity | CTSD | hsa1509 | |
Up-regulation | Expression | MAP1LC3A | hsa84557 | |
Up-regulation | Expression | MAP1LC3B | hsa81631 | |
Up-regulation | Expression | SQSTM1 | hsa8878 | |
In Vitro Model | Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_6898 |
Result | Ginsenoside Ro suppresses autophagy by interfering with autophagosome-lysosome fusion and lysosomal proteolytic activity via the ESR2-NCF1-ROS axis. Subsequently, such autophagic inhibition reduces CHEK1 degradation, enhances CHEK1-mediated DNA damage checkpoint arrest, and thereby sensitizes tumor cells to 5-Fu-induced cell death. |
No. | Title | Href |
---|---|---|
1 | Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint. Autophagy. 2016;12(9):1593-1613. doi:10.1080/15548627.2016.1192751 | Click |